1st Quarter - Report
W STRATEGIES, LLC for 23ANDME, INC.
Firm
Client
Income
$20,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
Issues related to regulation of Direct to Consumer (DTC) Genetic Testing, including FDA regulation of DTC tests and privacy in consumer genetics. H.R.4128: VALID Act of 2021.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.